newsolutionfordyslexia
Image
Image
Image

ChromaGen Lenses: A new solution for an age old problem.

Who

ChromaGen Vision is the company that owns the worldwide rights to the ChromaGen lens technology. The company owns approved patents in the United States for contact lenses and eyeglasses and has patents pending in Canada, Korea, Japan and the European Union. ChromaGen is the only FDA-cleared device that addresses the challenges that people have with dyslexia and reading disorders.More

What

ChromaGen® is a patented and FDA-cleared lens technology for the treatment of dyslexia and reading problems. It is non-invasive and does not involve surgery or chemicals and therefore has none of the traditional risks associated with medical devices and procedures. ChromaGen is available in eyeglasses, contacts and clip-ons. More

Why

The Chromagen lens technology was developed in response to people who were getting headaches, nausea and fatigue when reading due to seeing words that move on the page in some way.  The word movement is described as words that move from left to right or up and down, words that are blurry or come in and out of focus or words that appear to float on the page, seeing double words or  double sentences and re-reading the same lines. More

Quick Links